SureTrader Stock Hero Advertisement SureTrader
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Looking great today!!! Maybe there will be no

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Globaltrnr Member Profile
 
Followed By 65
Posts 7,326
Boards Moderated 0
Alias Born 10/12/09
160x600 placeholder
Advertisement
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/30/2015 1:11:57 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/29/2015 4:26:56 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/29/2015 4:24:19 PM
Arena Pharmaceuticals Reports Favorable Results from Phase 1 Single-Ascending Dose Clinical Trial of APD371 "PR Newswire (US)" - 4/29/2015 8:00:00 AM
Arena Pharmaceuticals Inc.'s Plan to Win the Obesity Drug War "The Motley Fool" - 4/24/2015 8:10:02 AM
3 Promising Small-Caps Under $10 You Can Buy Right Now "The Motley Fool" - 4/21/2015 9:06:02 AM
3 Promising Healthcare Stocks Under $10 "The Motley Fool" - 4/15/2015 8:02:02 AM
Arena's 15,000 Scripts Set Pace Vs. Competitors "Seeking Alpha" - 4/13/2015 11:00:47 AM
Orexigen: Contrave Scripts Dip - Were My Concerns About Advertising Right? "Seeking Alpha" - 4/13/2015 10:23:41 AM
Arena Gets Closer On Extended Release Formulation Of Belviq "Seeking Alpha" - 4/13/2015 7:59:01 AM
The Best Stock to Invest in Obesity Drugs "The Motley Fool" - 4/12/2015 2:03:03 PM
Arena's Partner Eisai Is Slashing Jobs - What Investors Need To Consider "Seeking Alpha" - 4/10/2015 10:27:12 AM
Arena secures new Belviq patent; Eisai cuts sales force "Seeking Alpha" - 4/10/2015 9:29:04 AM
Arena completes two Phase 1 trials for once-daily formulation of Belviq "Seeking Alpha" - 4/10/2015 8:48:57 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/10/2015 8:31:53 AM
Eisai and Arena Pharmaceuticals Complete Registrational Trials of an Extended Release Formulation of Lorcaserin "PR Newswire (US)" - 4/10/2015 8:00:00 AM
Novo Nordisk Quietly Becoming Big Player In Obesity Space "Seeking Alpha" - 4/9/2015 11:45:18 AM
Arena Pharmaceuticals to Present at the Annual Needham Healthcare Conference "PR Newswire (US)" - 4/9/2015 8:00:00 AM
Arena Pharmaceuticals Receives Additional Patent for BELVIQ® (lorcaserin HCl) from United States Patent and Trademark Office "PR Newswire (US)" - 4/7/2015 8:00:00 AM
NASH Series: Novo Nordisk And Cadila Healthcare "Seeking Alpha" - 4/4/2015 1:30:31 PM
Novo Nordisk Entry Is Bullish For The Anti-Obesity Space "Seeking Alpha" - 4/2/2015 9:20:16 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/1/2015 6:59:27 PM
Arena - Assessing Belviq In South Korea "Seeking Alpha" - 3/30/2015 7:57:55 PM
Arena: Belviq Sales Flatter Than Needed - Q1 Revenue Miss Likely "Seeking Alpha" - 3/28/2015 5:21:38 AM
Arena Investors Need To Pay Attention To Competition "Seeking Alpha" - 3/27/2015 7:59:45 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist